Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement


Back to Package

Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement

ACCC 37th National Oncology Conference 

This educational activity is jointly provided by AXIS Medical Education and ACCC

This activity is supported by educational grants from Abbvie,  AstraZeneca, GlaxoSmithKline, Lilly and Pfizer, Inc.

Release Date: 10/16/2020

Expire Date: 10/15/2021

Estimated Time to Complete: 75 minutes

Target audience: Physicians, nurses, APPs, pharmacists, pharmacy technicians, cancer program administrators, practice administrators, quality managers

Overview: Learn how a pharmacy resident project supported the creation and implementation of an oral oncolytic collaborative practice agreement (CPA) that expanded pharmacist scope of practice, decreased turnaround time for processing prescriptions, improved provider satisfaction, and decreased patient prescription costs. Today, St. Luke's Cancer Institute’s CPA allows pharmacists to sign prescriptions on behalf of providers for interventions such as renal or hepatic dose adjustments, dose rounding, renewal of prescription refills, adjustment for toxicities, dosing based on appropriate indication, and the ordering of laboratory tests and/or exams.

Learning Objectives:

At the end of this educational activity, participants should be able to:

  • Discuss the benefits of creating and implementing a collaborative pharmacist practice agreement to improve oral oncolytic workflow and reduce treatment delays

Faculty:

Amanda Wright, PharmD
Oncology Pharmacist
St. Luke's Cancer Institute

Julia Kerr, PharmD
Integrated Pharmacy Program Coordinator
St. Luke's Cancer Institute

ACCREDITED CONTINUING EDUCATION

Accreditation Statement

image

In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and ACCC.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

image

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation for Pharmacists
This knowledge-based activity is approved for 1.25 contact hours of continuing pharmacy education credit JA4008106-9999-20-061-H01-P.

Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Healthcare Executives
ACHE Qualified Education credit must be related to healthcare management (i.e., it cannot be clinical, inspirational, or specific to the sponsoring organization). It can be earned through educational programs conducted or sponsored by any organization qualified to provide education programming in healthcare management. Programs may be sponsored by ACHE, chapters, or other qualified sources, whether the programming is face-to-face or distance offerings (webinars, online seminars, self-study courses, etc.). You will receive a certificate of completion for 1.25 hours.

AXIS Contact Information
For information about the accreditation of this program please contact AXIS at info@axismeded.org.

Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Name of Faculty or Presenter/Planner

Reported Financial Relationship

Amanda Wright, PharmD

Nothing to disclose

Julia Kerr, PharmD

Nothing to disclose

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity: 

Name of Planner/Manager/Reviewer

Reported Financial Relationship

Leigh Boehmer, PharmD, BCOP

Nothing to disclose

Jay Carlson, DO

Nothing to disclose

Christina Fuller, BSW

Nothing to disclose

Tom A. Gallo, MS, MDA

Nothing to disclose

Marilyn L. Haas-Haseman, PhD, RN, CNS, ANP-BC

Nothing to disclose

Monique J. Marino

Nothing to disclose

Rebecca McMahon

Nothing to disclose

Kerri Michalik, MHA, BSN

Nothing to disclose

Dee Morgillo, MEd., MT(ASCP), CHCP

Nothing to disclose

Barbara Schmidtman, PhD

Nothing to disclose


Disclaimer   

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Method of Participation and Request for Credit    

  • Attend/participate in the educational activity and review all course materials. 

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

Julia Kerr, PharmD

Pharmacy Program Coordinator

I graduated from the University of Wyoming School of Pharmacy in 2002.  I went on to complete the Oncology Pharmacy Residency Program at St. Luke’s Cancer Institute in Boise, Idaho, the following year. Upon completion, I accepted an oncology pharmacy position at St. Luke’s where I worked for many years in the outpatient infusion pharmacy. For the past several years, I have transitioned to working exclusively with the Oral Oncology Pharmacy Program at St. Luke’s.  And in recent years, I have been the Pharmacy Program Coordinator for this department. I have had the pleasure of precepting many oncology pharmacy residents over the years and have enjoyed the opportunity to work with them on valuable projects, such as the one being presented at ACCC. I am also an active member with the National Community Oncology Dispensing Association (NCODA), where I currently serve as a Regional Leader.

Amanda Wright

Clinical Oncology Pharmacist

Amanda Wright, PharmD, has been a clinical oncology pharmacist since 2019. She received a bachelor’s degree in microbiology from the University of Idaho in 2013 and her Doctor of Pharmacy degree from Washington State University in 2017. Dr. Wright completed a generalized hospital pharmacy residency at St. Luke’s Boise Medical Center, and a specialized oncology pharmacy residency at St. Luke’s Cancer Institute, formerly Mountain States Tumor Institute. She currently works in the medically integrated pharmacy at St. Luke’s Cancer Institute and on the adult oncology floor in the St. Luke’s Boise Medical Center. Dr. Wright has been involved in the creation and implementation of the oral oncolytic collaborative practice agreement over the last two years. She enjoys spending her free time with her family and two Golden Retrievers and helps on the family cattle ranch when able.

Key:

Complete
Failed
Available
Locked
Pre-Test
4 Questions  |  1 attempt  |  0/4 points to pass
4 Questions  |  1 attempt  |  0/4 points to pass
Session Recording
Open to view video.
Open to view video.
Post-Test
4 Questions  |  3 attempts  |  3/4 points to pass
4 Questions  |  3 attempts  |  3/4 points to pass
Evaluation
12 Questions
CE Certificate
Up to 1.25 medical credits available  |  Certificate available
Up to 1.25 medical credits available  |  Certificate available